Updated Jul 16, 2026
Silver Ronald has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $834K.
Ronald Silver serves as the Principal Accounting Officer at Ironwood Pharmaceuticals Inc. He has been involved in financial oversight and reporting within the company, contributing to its operations in the pharmaceutical sector.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-09 | IRWD | IRONWOOD PHARMACEUTICALS INC | S — Open-market sale | 127.9K | $4.52 | $578K |
| 2026-05-21 | IRWD | IRONWOOD PHARMACEUTICALS INC | A — Grant or award | 25.0K | $0.00 | |
| 2026-03-12 | IRWD | IRONWOOD PHARMACEUTICALS INC | A — Grant or award | 163.9K | $0.00 | |
| 2026-02-25 | IRWD | IRONWOOD PHARMACEUTICALS INC | S — Open-market sale | 12.6K | $3.66 | $46K |
| 2026-02-25 | IRWD | IRONWOOD PHARMACEUTICALS INC | S — Open-market sale | 11.6K | $3.81 | $44K |
| 2026-01-07 | IRWD | IRONWOOD PHARMACEUTICALS INC | S — Open-market sale [10b5-1] | 35.4K | $4.60 | $163K |
| 2025-08-11 | IRWD | IRONWOOD PHARMACEUTICALS INC | S — Open-market sale | 2.8K | $0.84 | $2K |
Ronald Silver serves as the Principal Accounting Officer at Ironwood Pharmaceuticals Inc. He has been involved in financial oversight and reporting within the company, contributing to its operations in the pharmaceutical sector.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($834K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Silver Ronald profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.